Reading view
Publisher Correction: A scoping review on the mental health harms of LLM-based chatbots
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03240-x
Publisher Correction: A scoping review on the mental health harms of LLM-based chatbotsData-driven identification of repurposable drugs for ALS
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03225-w
Data-driven identification of repurposable drugs for ALSCirculating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9
Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.Rethinking the global health system for a new international order
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04622-0
In this Comment, we argue for a global health system that recognizes and supports countries as the primary agents of action, oriented around global public goods and collective action, and served by a leaner set of global and regional institutions. We present a potential vision for the functions and distribution of labor in the system to inform ongoing reform discussions and draw critique, dissent and amendment.Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-w
In the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM.Glycan recognition by a plant damage-sensing immune receptor
“Small” Large Language Models in the Hospital: Evaluation Study on Real-World Data in a Resource-Constrained Setting
Breaking timescales with generative sampling of conformational transitions
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11025-1
A generative committor-guided path-sampling framework reconstructs rare biomolecular transition pathways and reveals the underlying thermodynamics and kinetics without using predefined collective variables or brute-force sampling, at an acceptable computational cost.Neocortical long-range inhibition promotes cortical synchrony and sleep
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10876-y
In mice, a sparse population of sleep-active long-range inhibitory neurons in the neocortex promote widespread cortical synchronization and sleep, revealing a cortical mechanism that contributes to the regulation of sleep.Denisovans from southwestern China and their subsistence strategies
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10997-4
Evidence from Bianfu Cave shows specialized hunting, expedient stone-tool production and extensive bone use of Denisovans, providing new insights into their ecology, behaviour and cultural legacy in eastern Asia.Integrated signatures define mutational processes in prostate cancer
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10468-w
Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.Proximity-guided graph learning reveals tumour-associated proximity antigens
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11003-7
A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
Nature Medicine, Published online: 09 September 2026; doi:10.1038/s41591-026-04615-z
In a phase 2 randomized clinical trial, treatment with the myeloperoxidase (MPO) inhibitor mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial
npj Digital Medicine, Published online: 09 September 2026; doi:10.1038/s41746-026-03111-5
Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trialDesigning a Gamified mHealth App for HIV Prevention and Comorbidities Among Malaysian Young Men Who Have Sex With Men: An Interdisciplinary Expert Panel Study
Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switch
Nature, Published online: 07 September 2026; doi:10.1038/s41586-026-11103-4
Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switchSexual dimorphism in the complete Drosophila male central nervous system connectome
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01243-x
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialNeuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer
Oncogene, Published online: 01 September 2026; doi:10.1038/s41388-026-03969-5
Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer